The impact of symptoms and physiological abnormality in allergic skin disease on QOL and work impairment.

The impact of symptoms and physiological abnormality in allergic skin disease on QOL and work impairment. - The impact of allergic skin disease on patients' QOL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004283

Enrollment

400

Registered

2010-09-28

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

certain dermatoses including allergy and hidrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) chief complaint with "pruritus" b) over 8 years old, and regardless of gender c) regardless of in- and out patients

Exclusion criteria

Exclusion criteria: 1) patients with severe liver dysfunction 2)patients with a history of epilepsy 3) patients with drug allergy for antihistamines 4) excluding at a physician's direction

Design outcomes

Primary

Measure	Time frame
a) sudomotor function b) evaluation of intensity of itch by PAIN VISION. c) questionnaire survey for satisfaction level of their treatment d) visual analogue scale for itch e) Skindex-16 (QOL) f) Ped's QL (QOL) g) WPAI questionnaire h) State-Trait Anxiety Inventory-Form	—

Countries

Japan

Contacts

Public Contact0668795111

Osaka univeristy Dermatology

h-murota@derma.med.osaka-u.ac.jp0668795111

Outcome results